An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
2020-07-04
عنوان الدراسة
An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
داعم الدراسة
Boehringer Ingelheim
دواء الدراسة
BIBW 2992 / Vinorelbine / Trastuzumab
رقم بروتوكول الدراسة
1200.75
حالة الدراسة
Completed
موقع الدراسة
King Fahad Medical City (Riyadh), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。